CashuSoleno Therapeutics: Aardvark's Rise Signals Innovative Therapies in Biopharmaceuticals2 days ago
CashuSoleno Therapeutics: Aardvark's Biopharma Innovations Draws Positive Analyst Attention4 days ago
CashuSoleno Therapeutics Launches VYKAT™ XR for Prader-Willi Syndrome with LogiCare3PL's Logistics Innovations2 months ago
prnewswire.comLogiCare3PL Supports Commercial Launch of Soleno Therapeutics' VYKAT XR Following FDA Approval2 months ago
cnbc.comStocks making the biggest moves midday: General Motors, Petco, GameStop, Alibaba, Cava and more3 months ago
finance.yahoo.comSoleno Therapeutics (SLNO): Breakthroughs in Prader-Willi Syndrome Treatment9 months ago
finance.yahoo.comSoleno Therapeutics Announces Regulatory Update on DCCR (diazoxide choline) Extended-Release Tablets to Treat Prader-Willi Syndrome9 months ago
finance.yahoo.comSoleno Therapeutics to Present at 2024 Cantor Global Healthcare Conference10 months ago
finance.yahoo.comSoleno Therapeutics Announces U.S. FDA Acceptance for Filing and Priority Review of NDA for DCCR (Diazoxide Choline) Extended-Release Tablets in Prader-Willi Syndrome10 months ago